Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis

Stem Cells
Heeje KimCurt I Civin

Abstract

We sought to determine whether lympho-hematopoietic stem-progenitor cells (HSC) from human placental/umbilical cord blood (CB) or adult mobilized blood (PBSC) are sensitive to Fas-induced apoptosis. Human CD34+ cells from CB or PBSC were cultured in serum-free medium, with or without hematopoietic growth factors (FKT: FLT-3 ligand [FL], KIT ligand [KL], and thrombopoietin [TPO]), and with or without soluble Fas ligand (sFasL) or agonistic anti-Fas antibody. After 5-48 hours of culture, cells were assessed for viability and stained with Annexin V and 7-Aminoactinomycin D for apoptosis analysis by fluorescence-activated cell sorting. Cultured cells were also assessed by in vitro hematopoietic colony-forming cell (CFC) and in vivo nonobese diabetic/severe combined immunodeficient mouse engraftment potential (SEP) assays. Levels of Fas, FLICE inhibitory protein (FLIP), and Caspase 8 mRNA in CD34+ cells were determined by real-time quantitative polymerase chain reaction. Expression of FLIP was confirmed by Western blotting. No decrease in viability, CFC, or SEP was observed in CB or PBSC CD34+ cells cultured in the presence of sFasL or agonistic anti-Fas antibody. Human CB and mobilized PBSC CD34+ cells expressed high levels of FLIP...Continue Reading

References

Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·P RubinsteinC E Stevens
Nov 17, 1995·Science·T S GriffithT A Ferguson
Mar 10, 1995·Science·S Nagata, P Golstein
Sep 1, 1995·British Journal of Haematology·J P MaciejewskiN S Young
Oct 1, 1994·International Immunology·T TakahashiS Nagata
Mar 1, 1996·Nature Medicine·M TanakaS Nagata
Feb 7, 1997·Cell·S Nagata
May 1, 1997·Immunology Today·T S Griffith, T A Ferguson
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·D R Green, C F Ware
Jul 10, 1997·Nature·M IrmlerJ Tschopp
Jan 14, 1998·Nature Medicine·M TanakaS Nagata
Jan 9, 1999·The Journal of Biological Chemistry·C ScaffidiM E Peter
May 20, 1999·Transplantation Proceedings·R C DukeD Bellgrau
Jun 17, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·W LeungC I Civin
Jul 13, 1999·Transplantation·J Y Niederkorn
Dec 22, 1999·European Journal of Immunology·J WangM J Lenardo
Apr 5, 2000·The Journal of Experimental Medicine·A M HohlbaumA Marshak-Rothstein
Apr 14, 2000·Archives of Gynecology and Obstetrics·H IwamaN Nakamura
Aug 6, 2000·Immunology·E O'FlahertyJ A Kirby
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J L WahlstenR R Caspi
Mar 3, 2001·The New England Journal of Medicine·T Kamradt, N A Mitchison

❮ Previous
Next ❯

Citations

Sep 6, 2005·Bulletin of Experimental Biology and Medicine·V A Kozlov
Sep 7, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Joyce M KoenigKenneth O Schowengerdt
May 31, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Anne V Hall, Anthony M Jevnikar
Sep 10, 2003·Experimental Hematology·Bianling LiuJohannes C M van der Loo
Feb 25, 2006·Nature Reviews. Immunology·Ralph C BuddJürg Tschopp
Jun 19, 2002·The Journal of Clinical Investigation·Ronald Paquette, Kenneth Dorshkind
Jun 22, 2011·Pediatric Research·Ramachandran RashmiJoyce M Koenig
Oct 24, 2006·FEBS Letters·Claudia GiampietriAntonio Filippini
Feb 27, 2009·FEBS Letters·Graeme W CarlileMartin Wiedmann
Mar 10, 2011·Clinical Biochemistry·Gioacchin IannoloConcetta Conticello
Sep 27, 2003·British Journal of Haematology·Janina RatajczakMariusz Z Ratajczak
Mar 14, 2007·Journal of Cellular Physiology·Federica CoralliniGiorgio Zauli
Sep 18, 2007·Stem Cells·Michal Pearl-YafeNadir Askenasy
Mar 15, 2006·Blood Reviews·Eric J Burks, Thomas P Loughran
Sep 27, 2005·Leukemia Research·Peter GreaneyMichel A Duchosal
Apr 17, 2015·Journal of Radiation Research·Junya IshikawaIkuo Kashiwakura
Jun 6, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xiaobing YuLinzhao Cheng
Jul 10, 2007·Current Opinion in Immunology·Hideyuki Oguro, Atsushi Iwama
Feb 25, 2017·Journal of Cellular Physiology·Somnath MondalSwapna Chaudhuri
Oct 16, 2004·Blood·Nadir AskenasyHaval Shirwan
May 21, 2020·Bone Marrow Transplantation·Hilit Levy-BarazanyJerry Stein
Jan 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shinichiro YadaMichael J Pinkoski
Dec 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Francine RezzougSuzanne T Ildstad
May 14, 2020·International Journal of Molecular Sciences·Olga Raducka-JaszulAleksander F Sikorski
Oct 21, 2020·Leukemia·Stephanie N HurwitzPeter Kurre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis